Short Courses

Monday 18 March

9:30 – 12:30

SC1: The Tumour Microenvironment and Response to Cancer Immunotherapy - Detailed Agenda

Stephen A. Beers, PhD, Professor of Immunology and Immunotherapy, Centre for Cancer Immunology, University of Southampton

Awen Gallimore, DPhil, Professor, Immunology, Infection and Immunity, Cardiff University

SC2: Next Generation Immunotherapies - Detailed Agenda

1. Bispecific Antibodies: Formats, Considerations, Developability and Opportunities

Laura von Schantz, Director, Alligator Biosciences

2. Immunocytokines: New Formats and New Strategies

Dario Neri, PhD, Professor, Biomacromolecules, Chemistry and Applied Biosciences, ETH Zürich

3. Cellular Therapies: Current Successes and New Directions

Ryan McCoy, Lead Technical Scientist, Cell and Gene Therapy, Catapult

4. The Yin and the Yang of the Innate Immune System in Cancer Therapy

R.J. Tesi, MD, CEO and CMO, Inmune Bio

5. In vitro/ex vivo Models and Adapting in vivo Models to Study Immuno-Oncology and Antibody Functions

Sophia N. Karagiannis, BA, MS, PhD, Reader, Translational Cancer Immunology, St. John’s Institute of Dermatology, School of Basic & Medical Biosciences


18:30 - 21:30 (To Include Dinner)

SC3: Managing the Challenges of Bioassays for Immuno-Oncology - Detailed Agenda

Sofie Pattijn, CTO, ImmunXperts

Gisèle Deblandre, CSO, MaSTherCell


*Separate registration required

Register Now